OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
August 07, 2024
Platform processes and effective risk assessments help overcome time and cost challenges.
BioIVT opened new cleanroom manufacturing space, using Germfree’s technology to boost its capabilities for cell and gene therapy development.
August 06, 2024
The new additions to the company’s equipment at its early phase clinical manufacturing facility in Oregon will allow for cleaning, filling, capping, and sealing, and also detecting defects in drug products.
Manual and automated inspection technologies have their own advantages and limitations.
Freudenberg Medical has introduced custom single-use assemblies for silicone extrusion and molding for biopharma applications.
Webinar Date/Time: Thu, Aug 29, 2024 11:00 AM EDT
August 04, 2024
Innovative solutions are making personalized cell and gene therapies accessible to all.
August 01, 2024
The ROSS FDA-3500 dual shaft mixer is equipped with independently controlled drives and is designed to efficiently produce good turnover and impart shear to a viscous batch.
The NexGen Press 45 is the latest member of GEA Pharma & Healthcare’s NexGen Press line of tablet presses.
Syngene’s protein production platform uses a cell line and transposon-based technology licensed from Switzerland-based ExcellGene.